Lv2
198 积分 2024-06-13 加入
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer
9小时前
已完结
HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer
23天前
已完结
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
26天前
已完结
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
26天前
已完结
Pembrolizumab for Early Triple-Negative Breast Cancer
26天前
已完结
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
26天前
已完结
Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial
26天前
已完结
Hospital-based or home-based administration of oncology drugs? A micro-costing study comparing healthcare and societal costs of hospital-based and home-based subcutaneous administration of trastuzumab
1个月前
已完结
Targeting autophagy in doxorubicin-induced cardiotoxicity: A comprehensive review of scientific landscapes and therapeutic innovations
1个月前
已完结
An Intelligent Biomimetic Nanoplatform for Holistic Treatment of Metastatic Triple-Negative Breast Cancer via Photothermal Ablation and Immune Remodeling
4个月前
已完结
皖公网安备34019202002308
